Loading…

EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON TETRABENAZINE-INDUCED DEPLETION OF BRAIN MONOAMINES IN RATS. 2. DOPAMINE

We studied the effects of tricyclic antidepressants on the tetra-benazine (TB)-induced depletion of brain dopamine (DA) using rats. The test drugs were generally administered orally 3 hours before sacrifice and 2 mg/kg of TB or reserpine (RES) was administered subcutaneously 2 hours before sacrifice...

Full description

Saved in:
Bibliographic Details
Published in:Japanese journal of pharmacology 1981-06, Vol.31 (3), p.443-450
Main Authors: YOSHIZAKI, Toshio, TONDA, Kanya
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2027-cffb00ba5cfa08574dd15065974f98a9fa026910746d60dec39067322a7c88db3
container_end_page 450
container_issue 3
container_start_page 443
container_title Japanese journal of pharmacology
container_volume 31
creator YOSHIZAKI, Toshio
TONDA, Kanya
description We studied the effects of tricyclic antidepressants on the tetra-benazine (TB)-induced depletion of brain dopamine (DA) using rats. The test drugs were generally administered orally 3 hours before sacrifice and 2 mg/kg of TB or reserpine (RES) was administered subcutaneously 2 hours before sacrifice. The TB-induced DA depletion was enhanced by pretreatment with desmethylimipramine (DMI, 12.5–100 mg/kg), Imipramine (12.5–100 mg/kg), chlorimipramine (25–100 mg/kg), ami-triptyrine (100 mg/kg), maprotyrine (50 mg/kg) and chlorpromazine (5–20 mg/kg i.p.), while these drugs did not enhance RES-induced depletion. Observations to elucidate the action mechanism of antidepressant-induced enhancement were as follows. After TB administration, brain DA content was at the minimal level at 30 min after and on the way to recovery at 2 hours, but it approached the minimal level at 2 hours after RES administration. DMI pretreatment did not enhance the DA depletion at 0.5 hours after TB administration. In pargyline-pretreated rats, TB produced a decrease of brain DA with an increase of 3-methoxy-tyramine (3-MT), while RES showed only a slight effect on DA and 3-MT up to 2 hours. Amphetamine sulfate (20 mg/kg i.p.) slightly increased, while combinations with DMI decreased brain DA. These results suggest that tricyclic antidepressants inhibit DA reuptake from the synaptic cleft in vivo.
doi_str_mv 10.1016/S0021-5198(19)52851-7
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73768008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021519819528517</els_id><sourcerecordid>73768008</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2027-cffb00ba5cfa08574dd15065974f98a9fa026910746d60dec39067322a7c88db3</originalsourceid><addsrcrecordid>eNqFkF1PgzAUhhujmXP6E5b0yugFswVKy5Vh0CnJBguwC71poJQEsy_pZuK_t_vIbr1qz3nf95ycB4AhRiOMsPeSI2Rji2CfPWH_mdiMYItegT52XGo5BHnXoH-x3II7rb9MyRB2e6BHHYwx8fpgyycTHhY5TCewyOLwI5zGIQySIo74PON5br5GTGDBiywY8yT4jBNuxUm0CHkEjWnKi9joJj_OgjiBszRJg5kx5dBUWVDkI2iPYJTOj917cNOUS60ezu8ALCa8CN-tafoWh8HUkjayqSWbpkKoKolsSsQIdesam5uIT93GZ6VvurbnY0Rdr_ZQraTjI486tl1SyVhdOQPweJq77Tbfe6V3YtVqqZbLcq02ey2oQz2GEDNGcjLKbqN1pxqx7dpV2f0KjMSBtDiSFgeMAvviSNrEB2B4XrCvVqq-pM5ojf560pW58qdVndCyVWup6rZTcifqTfvPhj-CGYLX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73768008</pqid></control><display><type>article</type><title>EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON TETRABENAZINE-INDUCED DEPLETION OF BRAIN MONOAMINES IN RATS. 2. DOPAMINE</title><source>ScienceDirect Journals</source><creator>YOSHIZAKI, Toshio ; TONDA, Kanya</creator><creatorcontrib>YOSHIZAKI, Toshio ; TONDA, Kanya</creatorcontrib><description>We studied the effects of tricyclic antidepressants on the tetra-benazine (TB)-induced depletion of brain dopamine (DA) using rats. The test drugs were generally administered orally 3 hours before sacrifice and 2 mg/kg of TB or reserpine (RES) was administered subcutaneously 2 hours before sacrifice. The TB-induced DA depletion was enhanced by pretreatment with desmethylimipramine (DMI, 12.5–100 mg/kg), Imipramine (12.5–100 mg/kg), chlorimipramine (25–100 mg/kg), ami-triptyrine (100 mg/kg), maprotyrine (50 mg/kg) and chlorpromazine (5–20 mg/kg i.p.), while these drugs did not enhance RES-induced depletion. Observations to elucidate the action mechanism of antidepressant-induced enhancement were as follows. After TB administration, brain DA content was at the minimal level at 30 min after and on the way to recovery at 2 hours, but it approached the minimal level at 2 hours after RES administration. DMI pretreatment did not enhance the DA depletion at 0.5 hours after TB administration. In pargyline-pretreated rats, TB produced a decrease of brain DA with an increase of 3-methoxy-tyramine (3-MT), while RES showed only a slight effect on DA and 3-MT up to 2 hours. Amphetamine sulfate (20 mg/kg i.p.) slightly increased, while combinations with DMI decreased brain DA. These results suggest that tricyclic antidepressants inhibit DA reuptake from the synaptic cleft in vivo.</description><identifier>ISSN: 0021-5198</identifier><identifier>EISSN: 1347-3506</identifier><identifier>DOI: 10.1016/S0021-5198(19)52851-7</identifier><identifier>PMID: 7311156</identifier><language>eng</language><publisher>Japan</publisher><subject>Amphetamine - pharmacology ; Animals ; Antidepressive Agents, Tricyclic - pharmacology ; Brain Chemistry - drug effects ; Dopamine - metabolism ; Male ; Rats ; Reserpine - pharmacology ; Tetrabenazine - pharmacology</subject><ispartof>Japanese journal of pharmacology, 1981-06, Vol.31 (3), p.443-450</ispartof><rights>1981 Elsevier B.V.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2027-cffb00ba5cfa08574dd15065974f98a9fa026910746d60dec39067322a7c88db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021519819528517$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7311156$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>YOSHIZAKI, Toshio</creatorcontrib><creatorcontrib>TONDA, Kanya</creatorcontrib><title>EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON TETRABENAZINE-INDUCED DEPLETION OF BRAIN MONOAMINES IN RATS. 2. DOPAMINE</title><title>Japanese journal of pharmacology</title><addtitle>Jpn J Pharmacol</addtitle><description>We studied the effects of tricyclic antidepressants on the tetra-benazine (TB)-induced depletion of brain dopamine (DA) using rats. The test drugs were generally administered orally 3 hours before sacrifice and 2 mg/kg of TB or reserpine (RES) was administered subcutaneously 2 hours before sacrifice. The TB-induced DA depletion was enhanced by pretreatment with desmethylimipramine (DMI, 12.5–100 mg/kg), Imipramine (12.5–100 mg/kg), chlorimipramine (25–100 mg/kg), ami-triptyrine (100 mg/kg), maprotyrine (50 mg/kg) and chlorpromazine (5–20 mg/kg i.p.), while these drugs did not enhance RES-induced depletion. Observations to elucidate the action mechanism of antidepressant-induced enhancement were as follows. After TB administration, brain DA content was at the minimal level at 30 min after and on the way to recovery at 2 hours, but it approached the minimal level at 2 hours after RES administration. DMI pretreatment did not enhance the DA depletion at 0.5 hours after TB administration. In pargyline-pretreated rats, TB produced a decrease of brain DA with an increase of 3-methoxy-tyramine (3-MT), while RES showed only a slight effect on DA and 3-MT up to 2 hours. Amphetamine sulfate (20 mg/kg i.p.) slightly increased, while combinations with DMI decreased brain DA. These results suggest that tricyclic antidepressants inhibit DA reuptake from the synaptic cleft in vivo.</description><subject>Amphetamine - pharmacology</subject><subject>Animals</subject><subject>Antidepressive Agents, Tricyclic - pharmacology</subject><subject>Brain Chemistry - drug effects</subject><subject>Dopamine - metabolism</subject><subject>Male</subject><subject>Rats</subject><subject>Reserpine - pharmacology</subject><subject>Tetrabenazine - pharmacology</subject><issn>0021-5198</issn><issn>1347-3506</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><recordid>eNqFkF1PgzAUhhujmXP6E5b0yugFswVKy5Vh0CnJBguwC71poJQEsy_pZuK_t_vIbr1qz3nf95ycB4AhRiOMsPeSI2Rji2CfPWH_mdiMYItegT52XGo5BHnXoH-x3II7rb9MyRB2e6BHHYwx8fpgyycTHhY5TCewyOLwI5zGIQySIo74PON5br5GTGDBiywY8yT4jBNuxUm0CHkEjWnKi9joJj_OgjiBszRJg5kx5dBUWVDkI2iPYJTOj917cNOUS60ezu8ALCa8CN-tafoWh8HUkjayqSWbpkKoKolsSsQIdesam5uIT93GZ6VvurbnY0Rdr_ZQraTjI486tl1SyVhdOQPweJq77Tbfe6V3YtVqqZbLcq02ey2oQz2GEDNGcjLKbqN1pxqx7dpV2f0KjMSBtDiSFgeMAvviSNrEB2B4XrCvVqq-pM5ojf560pW58qdVndCyVWup6rZTcifqTfvPhj-CGYLX</recordid><startdate>198106</startdate><enddate>198106</enddate><creator>YOSHIZAKI, Toshio</creator><creator>TONDA, Kanya</creator><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198106</creationdate><title>EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON TETRABENAZINE-INDUCED DEPLETION OF BRAIN MONOAMINES IN RATS. 2. DOPAMINE</title><author>YOSHIZAKI, Toshio ; TONDA, Kanya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2027-cffb00ba5cfa08574dd15065974f98a9fa026910746d60dec39067322a7c88db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Amphetamine - pharmacology</topic><topic>Animals</topic><topic>Antidepressive Agents, Tricyclic - pharmacology</topic><topic>Brain Chemistry - drug effects</topic><topic>Dopamine - metabolism</topic><topic>Male</topic><topic>Rats</topic><topic>Reserpine - pharmacology</topic><topic>Tetrabenazine - pharmacology</topic><toplevel>online_resources</toplevel><creatorcontrib>YOSHIZAKI, Toshio</creatorcontrib><creatorcontrib>TONDA, Kanya</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>YOSHIZAKI, Toshio</au><au>TONDA, Kanya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON TETRABENAZINE-INDUCED DEPLETION OF BRAIN MONOAMINES IN RATS. 2. DOPAMINE</atitle><jtitle>Japanese journal of pharmacology</jtitle><addtitle>Jpn J Pharmacol</addtitle><date>1981-06</date><risdate>1981</risdate><volume>31</volume><issue>3</issue><spage>443</spage><epage>450</epage><pages>443-450</pages><issn>0021-5198</issn><eissn>1347-3506</eissn><abstract>We studied the effects of tricyclic antidepressants on the tetra-benazine (TB)-induced depletion of brain dopamine (DA) using rats. The test drugs were generally administered orally 3 hours before sacrifice and 2 mg/kg of TB or reserpine (RES) was administered subcutaneously 2 hours before sacrifice. The TB-induced DA depletion was enhanced by pretreatment with desmethylimipramine (DMI, 12.5–100 mg/kg), Imipramine (12.5–100 mg/kg), chlorimipramine (25–100 mg/kg), ami-triptyrine (100 mg/kg), maprotyrine (50 mg/kg) and chlorpromazine (5–20 mg/kg i.p.), while these drugs did not enhance RES-induced depletion. Observations to elucidate the action mechanism of antidepressant-induced enhancement were as follows. After TB administration, brain DA content was at the minimal level at 30 min after and on the way to recovery at 2 hours, but it approached the minimal level at 2 hours after RES administration. DMI pretreatment did not enhance the DA depletion at 0.5 hours after TB administration. In pargyline-pretreated rats, TB produced a decrease of brain DA with an increase of 3-methoxy-tyramine (3-MT), while RES showed only a slight effect on DA and 3-MT up to 2 hours. Amphetamine sulfate (20 mg/kg i.p.) slightly increased, while combinations with DMI decreased brain DA. These results suggest that tricyclic antidepressants inhibit DA reuptake from the synaptic cleft in vivo.</abstract><cop>Japan</cop><pmid>7311156</pmid><doi>10.1016/S0021-5198(19)52851-7</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-5198
ispartof Japanese journal of pharmacology, 1981-06, Vol.31 (3), p.443-450
issn 0021-5198
1347-3506
language eng
recordid cdi_proquest_miscellaneous_73768008
source ScienceDirect Journals
subjects Amphetamine - pharmacology
Animals
Antidepressive Agents, Tricyclic - pharmacology
Brain Chemistry - drug effects
Dopamine - metabolism
Male
Rats
Reserpine - pharmacology
Tetrabenazine - pharmacology
title EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON TETRABENAZINE-INDUCED DEPLETION OF BRAIN MONOAMINES IN RATS. 2. DOPAMINE
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A12%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EFFECTS%20OF%20TRICYCLIC%20ANTIDEPRESSANTS%20ON%20TETRABENAZINE-INDUCED%20DEPLETION%20OF%20BRAIN%20MONOAMINES%20IN%20RATS.%202.%20DOPAMINE&rft.jtitle=Japanese%20journal%20of%20pharmacology&rft.au=YOSHIZAKI,%20Toshio&rft.date=1981-06&rft.volume=31&rft.issue=3&rft.spage=443&rft.epage=450&rft.pages=443-450&rft.issn=0021-5198&rft.eissn=1347-3506&rft_id=info:doi/10.1016/S0021-5198(19)52851-7&rft_dat=%3Cproquest_cross%3E73768008%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2027-cffb00ba5cfa08574dd15065974f98a9fa026910746d60dec39067322a7c88db3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73768008&rft_id=info:pmid/7311156&rfr_iscdi=true